AID Life Science Holdings Limited provided unaudited earnings guidance for the six months ended 30 June 2019. The company is expected to record a significant decrease in loss for the six months ended 30 June 2019 as compared to that for the six months ended 30 June 2018, which was mainly attributable to significant decrease in fair value loss recognised as a result of fair value change of financial assets at fair value through profit or loss during the Period.